Free Trial

Synlogic (SYBX) Competitors

Synlogic logo
$1.12 -0.01 (-1.32%)
As of 05/22/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SYBX vs. STTK, HOWL, RENB, ICCC, DTIL, FBRX, ARTV, RNTX, BLUE, and PEPG

Should you be buying Synlogic stock or one of its competitors? The main competitors of Synlogic include Shattuck Labs (STTK), Werewolf Therapeutics (HOWL), Renovaro (RENB), ImmuCell (ICCC), Precision BioSciences (DTIL), Forte Biosciences (FBRX), Artiva Biotherapeutics (ARTV), Rein Therapeutics (RNTX), bluebird bio (BLUE), and PepGen (PEPG). These companies are all part of the "pharmaceutical products" industry.

Synlogic vs.

Synlogic (NASDAQ:SYBX) and Shattuck Labs (NASDAQ:STTK) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, community ranking, media sentiment and valuation.

Shattuck Labs has a consensus price target of $7.50, indicating a potential upside of 650.00%. Given Shattuck Labs' stronger consensus rating and higher probable upside, analysts plainly believe Shattuck Labs is more favorable than Synlogic.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Synlogic
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Shattuck Labs
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.71

In the previous week, Synlogic's average media sentiment score of 0.00 equaled Shattuck Labs'average media sentiment score.

Company Overall Sentiment
Synlogic Neutral
Shattuck Labs Neutral

63.4% of Synlogic shares are held by institutional investors. Comparatively, 58.7% of Shattuck Labs shares are held by institutional investors. 3.0% of Synlogic shares are held by company insiders. Comparatively, 10.5% of Shattuck Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Synlogic has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, Shattuck Labs has a beta of 1.74, meaning that its share price is 74% more volatile than the S&P 500.

Synlogic received 292 more outperform votes than Shattuck Labs when rated by MarketBeat users. However, 69.64% of users gave Shattuck Labs an outperform vote while only 69.54% of users gave Synlogic an outperform vote.

CompanyUnderperformOutperform
SynlogicOutperform Votes
331
69.54%
Underperform Votes
145
30.46%
Shattuck LabsOutperform Votes
39
69.64%
Underperform Votes
17
30.36%

Synlogic has higher earnings, but lower revenue than Shattuck Labs. Shattuck Labs is trading at a lower price-to-earnings ratio than Synlogic, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Synlogic$8K1,628.23-$57.28M-$2.51-0.44
Shattuck Labs$4.61M10.40-$87.30M-$1.39-0.72

Synlogic has a net margin of 0.00% compared to Shattuck Labs' net margin of -1,156.46%. Shattuck Labs' return on equity of -61.92% beat Synlogic's return on equity.

Company Net Margins Return on Equity Return on Assets
SynlogicN/A -207.84% -114.81%
Shattuck Labs -1,156.46%-61.92%-54.49%

Summary

Shattuck Labs beats Synlogic on 11 of the 17 factors compared between the two stocks.

Get Synlogic News Delivered to You Automatically

Sign up to receive the latest news and ratings for SYBX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SYBX vs. The Competition

MetricSynlogicPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$13.33M$6.47B$5.33B$8.39B
Dividend YieldN/A2.64%5.21%4.11%
P/E Ratio-0.279.0626.7119.71
Price / Sales1,628.23251.51386.08120.53
Price / CashN/A65.8538.2534.62
Price / Book0.246.456.774.50
Net Income-$57.28M$143.98M$3.23B$248.22M
7 Day Performance3.12%0.38%0.48%-0.78%
1 Month Performance-2.82%2.14%9.10%11.53%
1 Year Performance-29.51%-0.33%18.56%8.99%

Synlogic Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SYBX
Synlogic
N/A$1.11
-2.3%
N/A-30.4%$13.33M$8,000.00-0.2780Upcoming Earnings
STTK
Shattuck Labs
2.5606 of 5 stars
$1.05
-4.5%
$7.50
+614.3%
-86.9%$50.29M$4.61M-0.69100
HOWL
Werewolf Therapeutics
3.2714 of 5 stars
$1.12
+0.9%
$8.33
+644.0%
-77.3%$50.26M$1.14M-0.7340
RENB
Renovaro
0.8222 of 5 stars
$0.32
-1.9%
N/A-64.5%$50.12MN/A-0.3420News Coverage
Gap Up
ICCC
ImmuCell
0.1875 of 5 stars
$5.48
+4.0%
N/A+31.2%$49.52M$26.49M-10.9670Gap Up
DTIL
Precision BioSciences
3.4318 of 5 stars
$4.69
-0.4%
$47.00
+902.1%
-64.5%$49.48M$68.70M78.18200Earnings Report
Analyst Forecast
FBRX
Forte Biosciences
2.6153 of 5 stars
$7.50
-4.5%
$32.50
+333.3%
+31,233.3%$49.37MN/A-0.465News Coverage
Earnings Report
Analyst Downgrade
ARTV
Artiva Biotherapeutics
1.6879 of 5 stars
$2.02
-0.5%
$19.40
+860.4%
N/A$49.21M$251,000.000.0081
RNTX
Rein Therapeutics
N/A$2.15
-2.7%
N/AN/A$48.96MN/A-0.699Earnings Report
BLUE
bluebird bio
2.7122 of 5 stars
$4.98
+0.2%
$44.60
+795.6%
-74.6%$48.76M$83.81M-0.13520
PEPG
PepGen
2.9125 of 5 stars
$1.49
-3.2%
$9.67
+548.8%
-89.5%$48.75MN/A-0.5030

Related Companies and Tools


This page (NASDAQ:SYBX) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners